Camber Pharmaceuticals launches generic Esbriet

Print Friendly, PDF & Email

PISCATAWAY, N.J.– Camber Pharmaceuticals announced the addition of Pirfenidone Tablets to its current portfolio.

Pirfenidone Tablets are indicated for the treatment of idiopathic pulmonary fibrosis (IPF).

Pirfenidone Tablets from Camber are available in two strengths:

  • 267 mg in 3 pack/ 90 count bottles (270 count total)
  • 801 mg strength in 90 count bottles


Adheris Health

Comments are closed.

Adheris Health